Liu, N., Feng, J., Lu, X., Yao, Z., Liu, Q., Lv, Y., . . . Zhou, Y. (2019). Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways. Mediators Inflamm.

Liu, Ning, Jiao Feng, Xiya Lu, Zhilu Yao, Qing Liu, Yang Lv, Yuru Han, Jingfan Deng, and Yingqun Zhou. "Isorhamnetin Inhibits Liver Fibrosis By Reducing Autophagy and Inhibiting Extracellular Matrix Formation Via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways." Mediators Inflamm 2019.

Liu, Ning, et al. "Isorhamnetin Inhibits Liver Fibrosis By Reducing Autophagy and Inhibiting Extracellular Matrix Formation Via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways." Mediators Inflamm 2019.